A case of paranoid schizophrenia complicated by scleroderma with associated esophageal dysmotility.
Shibley
Heather
H
Medical University of South Carolina, Charleston, USA.
Pelic
Chris
C
Kahn
David A
DA
D000284:Administration, Oral; D000328:Adult; D014150:Antipsychotic Agents / Q000008:administration & dosage; D001569:Benzodiazepines / Q000008:administration & dosage; D019090:Case Management; D003134:Commitment of Persons with Psychiatric Disorders; D003520:Cyclophosphamide / Q000008:administration & dosage; D003937:Diagnosis, Differential; D004347:Drug Interactions; D004750:Enteral Nutrition / Q000523:psychology; D004931:Esophageal Achalasia / Q000150:complications* / Q000175:diagnosis / Q000188:drug therapy / Q000523:psychology; D005260:Female; D006220:Haloperidol / Q000008:administration & dosage; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage; D000077152:Olanzapine; D010342:Patient Acceptance of Health Care / Q000523:psychology; D010348:Patient Care Team; D010552:Personality Assessment; D011241:Prednisone / Q000008:administration & dosage; D012017:Referral and Consultation; D012563:Schizophrenia, Paranoid / Q000150:complications* / Q000175:diagnosis / Q000188:drug therapy / Q000523:psychology; D012595:Scleroderma, Systemic / Q000150:complications* / Q000175:diagnosis / Q000188:drug therapy / Q000523:psychology; D016312:Treatment Refusal / Q000523:psychology; D015431:Weight Loss
D014150:Antipsychotic Agents; D007166:Immunosuppressive Agents; D001569:Benzodiazepines; D003520:Cyclophosphamide; D006220:Haloperidol; D000077152:Olanzapine; D011241:Prednisone